INTRODUCTION: Serous peritoneal papillary carcinoma (SPPC), though managed
according to ovarian cancer therapeutic principles, has been variably considered as an …

Since the establishment of extraovarian peritoneal serous papillary carcinoma (EPSPC) as a
clinical entity in 1959, less than 250 cases have been described and its clinicopathologic …

Extraovarian primary peritoneal carcinoma (EOPPC), a relatively newly defined disease that
develops only in women, accounts for approximately 10% of cases with a presumed …

Objective. To determine the pathological, clinical, and therapeutic factors which had
prognostic significance in women with extraovarian primary peritoneal carcinoma (EOPPC) …

OBJECTIVES: The goals of this study were first, to assess the clinical effectiveness of
cisplatin and cyclophosphamide in a phase II study involving a well-defined group of women …

Primary neoplasms of the female peritoneum may be mesothelial or Müllerian in nature.
Primary mesotheliomas may be cystic, benign papillary or diffuse malignant. Primary …

Objectives. The aim of the current study is to evaluate the results of therapy with induction
with weekly cisplatin followed by the combination of cisplatin–doxorubicin …

Serous peritoneal papillary carcinoma (SPPC) represents a particular cancer of unknown
primary (CUP) entity that arises in the peritoneal surface lining the abdomen and pelvis …

Abstract Background and Objectives Our knowledge regarding the pathologic lymphatic
spread pattern of primary peritoneal carcinoma (PPC) is limited. The aim of this study was to …

Primary tumors of the peritoneum are rare. Histological differentiation between papillary
mesotheliomas, primary ovarian tumors, borderline tumors of the ovary with peritoneal …